Concomitant treatment with other alpha-blockers or phosphodiesterase type 5 inhibitors should be avoided because of the increased risk for symptomatic hypotension.
当同时使用其他的α-受体阻滞剂或5磷酸二酯酶抑制剂时，应避免增加低血压症状发生的风险。
Concomitant treatment with other alpha-blockers or phosphodiesterase type 5 inhibitors should be avoided because of the increased risk for symptomatic hypotension.
当同时使用其他的α-受体阻滞剂或5磷酸二酯酶抑制剂时，应避免增加低血压症状发生的风险。
应用推荐